One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...